Analysed GOSSAMER BIO INC (GOSS:NASDAQ) News Sources
Gossamer Bio Announces Up to $250 Million Structured Private Placement, Including $150 Million of Committed Capital, to Fund Seralutinib Through Potential FDA Approval
21-08-2026
yahoo.com
Gossamer Bio Agrees to Up to $250 Million Private Placement; Shares Rise Pre-Bell
21-08-2026
yahoo.com
Gossamer Bio Secures Up to $250 Million Private Placement to Fund Seralutinib Through Potential FDA Approval
21-08-2026
advfn.com
Gossamer Bio announces $250m in funding to advance seralutinib
24-08-2026
pharmaceutical-technology.com
Gossamer (GOSS) Announced Up to $250M of Financing, but Only $25M is Expected Upfront. Is the Runway Secure?
27-08-2026
yahoo.com
Assessment of the Pulmonary Arterial Hypertension (PAH) Market 2026-2036 Featuring United Therapeutics, Mochida Pharmaceutical, Johnson & Johnson, Merck, and Gossamer Bio
08-09-2026
yahoo.com
Gossamer Bio Submits New Drug Application to U.S. FDA for Seralutinib for the Treatment of Pulmonary Arterial Hypertension
23-09-2026
yahoo.com
What is the current price of GOSSAMER BIO INC (GOSS:NASDAQ)?
The current price of GOSSAMER BIO INC (GOSS:NASDAQ) is $9.31.
GOSSAMER BIO INC (GOSS:NASDAQ) absolute price change since previous trading day?
The absolute price change of GOSSAMER BIO INC (GOSS:NASDAQ) since the previous trading day is $-0.57.
GOSSAMER BIO INC (GOSS:NASDAQ) percentage price change since previous trading day?
The percentage price change of GOSSAMER BIO INC (GOSS:NASDAQ) since the previous trading day is -5.7692%.
What is the most recent average sentiment score for GOSSAMER BIO INC (GOSS:NASDAQ)?
The most recent average sentiment score for GOSSAMER BIO INC (GOSS:NASDAQ) is 87 out of 100.
What is the most recent average sentiment for GOSSAMER BIO INC (GOSS:NASDAQ)?
The most recent sentiment for GOSSAMER BIO INC (GOSS:NASDAQ) is .
SEC-8K** Filing Available For GOSSAMER BIO INC (GOSS:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.